Project Grant HT94252410229
Award Date 6/1/24
Completion Date 5/31/28
Dollars Obligated $2.7M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Denver, CO 80206, USA
Similar Awards
- National Jewish Health received a $766,910 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from June 1, 2023 to May 31, 2027 to investigate incretin mimetics and thiazolidinediones as potential therapies to reduce excessive airway mucus and improve lung function in COPD patients. Through this award, National Jewish Health will leverage its expertise in pulmonary and...
- The National Jewish Health in Denver, Colorado will receive $5.14 million through June 2026 under a Project Grant from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve health care for service members and the public. Through this funding, National Jewish Health will conduct research on lung repair using the tetraspanin interacting protein IGSF3. The goal is to...
- The National Jewish Health will receive $1,837,687 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research on innate immunity and deployment-related lung diseases from September 30, 2021 through September 29, 2024. This Project Grant will support the organization's efforts to investigate medical solutions for the battlefield by transforming health care for service members and the public through innovative...
- The National Jewish Health will receive $1,802,392 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to investigate ceramide's role in COVID-19 vascular injury and acute respiratory distress syndrome (ARDS) from September 30, 2022 through September 29, 2026. The goal of this Project Grant award is to transform health care for service members and the public through innovative biomedical research that seeks to understand how...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,217,668.00 to the Medstar Health Research Institute Inc. for a research project titled "Toxic Products of Combustion in Burn and Smoke Inhalation Injuries". The performance period runs from September 1, 2024 through October 31, 2027. The Medstar Health Research Institute Inc., a non-profit healthcare research organization, will conduct...
- The $2,013,978 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by New York University (NYU) School of Medicine to investigate the metabolic impacts and mitigation strategies for particulate matter exposure. The project aims to study the molecular pathways involved in the RAGE (Receptor for Advanced Glycation Endproducts) system and its role in mediating metabolic dysregulation after particulate matter...
- This $2,488,002.00 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a multi-year research effort by the University of Colorado-Denver to develop biomarkers for detecting acute, subacute, and chronic organ injury following neonatal congenital heart disease surgery. The research aims to improve diagnostic capabilities and treatment outcomes for this patient population. The award runs from April 1, 2024 to March 31, 2028, and...
- The Department of Defense's Defense Health Agency has awarded a $866,250 Project Grant to the Trustees of Boston University, doing business as the Boston University Medical Campus, under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2024, will fund a research project titled "TARGETING TRANSCRIPTIONAL NETWORKS DIRECTING IMMUNE EVASION IN PROGRESSIVE BRONCHIAL PREMALIGNANT LESIONS" through June 30, 2027. As a leading private research...
- The federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a $1,126,946 research initiative aimed at cardiovascular risk profiling of deployment-related respiratory diseases. The grant was awarded on November 1, 2024 to the Veterans Bio-Medical Research Institute, Inc., a non-profit research organization located in East Orange, New Jersey. This translational research project investigates innovative...
- This $345,800 Project Grant was awarded on May 1, 2024 by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Boston, Massachusetts. The grant supports research on the "Role of Stress Granules in the Pathogenesis and Therapy of Pulmonary Hypertension", with a performance period from May 1, 2024 to April 30, 2026. The Military Medical Research and Development program funds a...